ReleaseWire

Global Markets Direct's, 'Swine Influenza - Pipeline Review, H1 2014', provides an overview of the Swine Influenza's therapeutic pipeline.

Global Markets Direct's, 'Fibrocell Science, Inc. - Product Pipeline Review - 2014', provides an overview of the Fibrocell Science, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Senju Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Senju Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Refractory Leukemia - Pipeline Review, H1 2014', provides an overview of the Refractory Leukemia's therapeutic pipeline.

Global Markets Direct's, 'General Anxiety Disorder - Pipeline Review, H1 2014', provides an overview of the General Anxiety Disorder's therapeutic pipeline.

Global Markets Direct's, 'Moderate Pain - Pipeline Review, H1 2014', provides an overview of the Moderate Pain's therapeutic pipeline.

CEL-SCI Corporation announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted regulatory approval to begin the Company’s Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection) in the United Kingdom (UK). The UK becomes the 13th country to join the trial. Several hospitals and medical clinics in the UK are expected to participate in the Phase III trial for the treatment of head and neck cancer.

Premature Labor (Tocolysis) - Pipeline Review, H1 2014

Global Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

GlobalData's clinical trial report, "Type 2 Diabetes Global Clinical Trials Review, H1, 2014" provides data on the Type 2 Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 2 Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type 2 Diabetes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Ischemic Cerebral Stroke - Pipeline Review, H1 2014', provides an overview of the Ischemic Cerebral Stroke's therapeutic pipeline.

Epstein-Barr Viral Infections - Pipeline Review, H1 2014

Global Markets Direct's, 'Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2014', provides an overview of the Cerebral Infarction (Brain Infarction)'s therapeutic pipeline.

Global Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Global Markets Direct's, 'Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2014', provides an overview of the Juvenile Macular Degeneration (Stargardt Disease)'s therapeutic pipeline.

Pharmaceuticals in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Czech Republic pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Global Markets Direct's, 'Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2014', provides an overview of the Refractory Acute Myeloid Leukemia's therapeutic pipeline.

Global Markets Direct's, 'Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014', provides an overview of the Cadila Pharmaceuticals Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2014', provides an overview of the Neuromyelitis Optica (Devic's Syndrome)'s therapeutic pipeline.

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2014

Global Markets Direct's, 'Nocturia - Pipeline Review, H1 2014', provides an overview of the Nocturia's therapeutic pipeline.

GlobalData's clinical trial report, "Primary Hyperparathyroidism Global Clinical Trials Review, H1, 2014" provides data on the Primary Hyperparathyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Primary Hyperparathyroidism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Primary Hyperparathyroidism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Mixed Dyslipidemia - Pipeline Review, H1 2014', provides an overview of the Mixed Dyslipidemia's therapeutic pipeline.

The present report on "Europe Nutraceuticals Industry Outlook to 2017 - Improving Economic Conditions to Propel Growth" gives a comprehensive analysis with past, present and future outlook of the nutraceutical industry. The report discusses the UK, Germany, France and Italy nutraceutical markets with future prospects till 2017. The study also entails major industry segments such as functional food, functional beverages and dietary supplements and sub-segments of the market. Additionally, the report has discussed supporting factors such as ongoing trends and developments, government regulations and has highlighted major players operating in the industry with their market share and profiles.